Authors
Neil E Moat, Peter Ludman, Mark A De Belder, Ben Bridgewater, Andrew D Cunningham, Christopher P Young, Martyn Thomas, Jan Kovac, Tom Spyt, Philip A MacCarthy, Olaf Wendler, David Hildick-Smith, Simon W Davies, Uday Trivedi, Daniel J Blackman, Richard D Levy, Stephen JD Brecker, Andreas Baumbach, Tim Daniel, Huon Gray, Michael J Mullen
Publication date
2011/11/8
Journal
Journal of the American College of Cardiology
Volume
58
Issue
20
Pages
2130-2138
Publisher
American College of Cardiology Foundation
Description
Objectives
The objective was to define the characteristics of a real-world patient population treated with transcatheter aortic valve implantation (TAVI), regardless of technology or access route, and to evaluate their clinical outcome over the mid to long term.
Background
Although a substantial body of data exists in relation to early clinical outcomes after TAVI, there are few data on outcomes beyond 1 year in any notable number of patients.
Methods
The U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry was established to report outcomes of all TAVI procedures performed within the United Kingdom. Data were collected prospectively on 870 patients undergoing 877 TAVI procedures up until December 31, 2009. Mortality tracking was achieved in 100% of patients with mortality status reported as of December 2010.
Results
Survival at 30 days was 92.9%, and it was 78.6% and 73.7% at 1 year …
Total citations
Scholar articles
NE Moat, P Ludman, MA De Belder, B Bridgewater… - Journal of the American College of Cardiology, 2011